Compound heterozygous mutation of theASXL3gene causes autosomal recessive congenital heart disease
Compound heterozygous mutation of theASXL3gene causes autosomal recessive congenital heart disease
复制标题
ASXL3基因复合杂合突变导致常染色体隐性遗传先天性心脏病
DOI:
10.1007/s00439-020-02200-z
复制
发表时间:
2020-07-21
期刊:
影响因子:
5.3
通讯作者:
Liao, Can
中科院分区:
文献类型:
--
作者:
Fu, Fang;Li, Ru;Liao, Can
To explore mutations in the additional sex combs-like 3 (ASXL3) gene in two Chinese families with congenital heart disease (CHD). Whole-exome sequencing (WES) was used to reveal a novel compound heterozygous mutation in theASXL3gene that was associated with CHD. Sanger sequencing of a further 122 CHD patients was used to determine an additional compound heterozygous mutation in theASXL3gene. Cell apoptosis was examined by MTS assay and flow cytometry. The cardiac structure was identified via hematoxylin-eosin (HE), Masson's trichrome, and ultrasound scanning. RNA sequencing was performed to identify a series of differentially expressed mRNAs. The mRNA and protein expressions were identified by quantitative real-time PCR and western blotting, respectively. A compound heterozygous mutation c.2168C > G (p.Pro723Arg) and c.5449C > G (p.Pro1817Ala) in theASXL3gene associated with CHD was identified. Overexpression of this compound heterozygous mutation in HL-1 cells resulted in increased apoptosis and reduced cell viability. Moreover, it affected cardiac structure and fibrosis in mice. There were 126 downregulated mRNAs and 117 upregulated mRNAs between theASXL3compound heterozygous mutation c.2168C > G (p.Pro723Arg) and c.5449C > G (p.Pro1817Ala) mice and wild-type mice.Ezh2,Slc6a4, andSocs3, which could interact withASXL3through proteins, were all upregulated. Another compound heterozygous mutation c.3526C > T (p.Arg1176Trp) and c.4643A > G (p.Asp1548Gly) in theASXL3gene was identified by screening a further 122 patients with CHD. TheASXL3gene is important in cardiac development and may exert this influence by affecting the expression of mRNAs associated with cell apoptosis and cell proliferation.